Ceftazidime/avibactam resistance is associated with PER-3-producing ST309 lineage in Chilean clinical isolates of non-carbapenemase producing Pseudomonas aeruginosa
dc.contributor.author | Soto, Katherine D. | |
dc.contributor.author | Alcalde-Rico, Manuel | |
dc.contributor.author | Ugalde, Juan A. | |
dc.contributor.author | Olivares-Pacheco, Jorge | |
dc.contributor.author | Quiroz, Valeria | |
dc.contributor.author | Brito, Bárbara | |
dc.contributor.author | Rivas, Lina M. | |
dc.contributor.author | Munita, José M. | |
dc.contributor.author | García, Patricia C. | |
dc.contributor.author | Wozniak, Aniela | |
dc.date.accessioned | 2024-07-19T15:48:31Z | |
dc.date.available | 2024-07-19T15:48:31Z | |
dc.date.issued | 2024 | |
dc.description | Indexación: Scopus. | |
dc.description.abstract | Introduction: Ceftazidime/avibactam (CZA) is indicated against multidrug-resistant Pseudomonas aeruginosa, particularly those that are carbapenem resistant. CZA resistance in P. aeruginosa producing PER, a class A extended-spectrum β-lactamase, has been well documented in vitro. However, data regarding clinical isolates are scarce. Our aim was to analyze the contribution of PER to CZA resistance in non-carbapenemase-producing P. aeruginosa clinical isolates that were ceftazidime and/or carbapenem non-susceptible. Methods: Antimicrobial susceptibility was determined through agar dilution and broth microdilution, while blaPER gene was screened through PCR. All PER-positive isolates and five PER-negative isolates were analyzed through Whole Genome Sequencing. The mutational resistome associated to CZA resistance was determined through sequence analysis of genes coding for PBPs 1b, 3 and 4, MexAB-OprM regulators MexZ, MexR, NalC and NalD, AmpC regulators AmpD and AmpR, and OprD porin. Loss of blaPER-3 gene was induced in a PER-positive isolate by successive passages at 43°C without antibiotics. Results: Twenty-six of 287 isolates studied (9.1%) were CZA-resistant. Thirteen of 26 CZA-resistant isolates (50%) carried blaPER. One isolate carried blaPER but was CZA-susceptible. PER-producing isolates had significantly higher MICs for CZA, amikacin, gentamicin, ceftazidime, meropenem and ciprofloxacin than non-PER-producing isolates. All PER-producing isolates were ST309 and their blaPER-3 gene was associated to ISCR1, an insertion sequence known to mobilize adjacent DNA. PER-negative isolates were classified as ST41, ST235 (two isolates), ST395 and ST253. PER-negative isolates carried genes for narrow-spectrum β-lactamases and the mutational resistome showed that all isolates had one major alteration in at least one of the genes analyzed. Loss of blaPER-3 gene restored susceptibility to CZA, ceftolozane/tazobactam and other β-lactamsin the in vitro evolved isolate. Discussion: PER-3-producing ST309 P. aeruginosa is a successful multidrug-resistant clone with blaPER-3 gene implicated in resistance to CZA and other β-lactams. | |
dc.description.uri | https://www-scopus-com.recursosbiblioteca.unab.cl/record/display.uri?eid=2-s2.0-85196292950&origin=resultslist&sort=plf-f&src=s&nlo=&nlr=&nls=&sid=dbd85ca00ec1299adff19f78e4cdb00d&sot=aff&sdt=cl&cluster=scofreetoread%2c%22all%22%2ct&sl=34&s=AF-ID%2860002636%29+AND+SUBJAREA%28IMMU%29&relpos=18&citeCnt=0&searchTerm= | |
dc.identifier.citation | Frontiers in Cellular and Infection Microbiology Open Access Volume 142024 Article number 1410834 | |
dc.identifier.doi | 10.3389/fcimb.2024.1410834 | |
dc.identifier.issn | 22352988 | |
dc.identifier.uri | https://repositorio.unab.cl/handle/ria/58606 | |
dc.language.iso | en | |
dc.publisher | Frontiers Media SA | |
dc.rights.license | CC BY 4.0 ATTRIBUTION 4.0 INTERNATIONAL | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
dc.subject | blaPER-3 gene | |
dc.subject | ceftazidime/avibactam resistance | |
dc.subject | mutations conferring CZA resistance | |
dc.subject | PER-3 extended-spectrum β-lactamase | |
dc.subject | Pseudomonas aeruginosa | |
dc.title | Ceftazidime/avibactam resistance is associated with PER-3-producing ST309 lineage in Chilean clinical isolates of non-carbapenemase producing Pseudomonas aeruginosa | |
dc.type | Artículo |
Archivos
Bloque original
1 - 1 de 1
No hay miniatura disponible
- Nombre:
- Ceftazidimeavibactam-resistance-is-associated-with-PER3producing-ST309-lineage-in-Chilean-clinical-isolates-of-noncarbapenemase-producing-Pseudomonas-aeruginosa.pdf
- Tamaño:
- 1.85 MB
- Formato:
- Adobe Portable Document Format
- Descripción:
- TEXTO COMPLETO EN INGLÉS
Bloque de licencias
1 - 1 de 1
No hay miniatura disponible
- Nombre:
- license.txt
- Tamaño:
- 1.71 KB
- Formato:
- Item-specific license agreed upon to submission
- Descripción: